“…Hydrophilic polymers have been widely applied in drug delivery systems [ 15 ] in form of nanoparticles [ 16 , 17 ], microspheres [ 18 ], self-emulsifying systems [ 19 ], micelles [ 20 , 21 ], cubosomes [ 22 ], ophthalmic formulations [ 23 ], transdermal delivery [ 24 ], nano-solutions [ 25 ], and controlled release matrix formulations [ 26 ]. For example, several studies have been conducted with the hydrophobic polymer P-188 and/or P-407 to develop stable and controlled release dosage formulations for therapeutic agents, including diclofenac sodium [ 26 ], theophylline [ 27 ], methotrexate [ 28 ], morphine [ 29 ], vancomycin [ 30 ], tetramethylpyrazine [ 31 ], indomethacin [ 32 ], ibuprofen [ 33 ], and ketorolac tromethamine [ 34 ]. To the best of our knowledge, no research has been performed yet on developing a controlled release matrix system for SDF using P-188 or another type of polymer.…”